SynthesisCardiology journal2022

Cardiovascular outcomes with glucagon-like peptide 1 agonists and sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: A meta-analysis.

Yeong-Min Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.